Challenges in interpreting SARS-CoV-2 serological results in African countries.
作者信息
Nkuba Ndaye Antoine, Hoxha Ana, Madinga Joule, Mariën Joachim, Peeters Martine, Leendertz Fabian H, Ahuka Mundeke Steve, Ariën Kevin K, Muyembe Tanfumu Jean-Jacques, Mbala Kingebeni Placide, Vanlerberghe Veerle
机构信息
Department of Virology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; Institut de Recherche pour le Développement, University of Montpellier, Montpellier, France.
Tropical Infectious Diseases Unit, Department of Public Health, 2000 Antwerp, Belgium; Institute of Tropical Medicine, 2000 Antwerp, Belgium.
出版信息
Lancet Glob Health. 2021 May;9(5):e588-e589. doi: 10.1016/S2214-109X(21)00060-7. Epub 2021 Feb 17.
Abstract
摘要
相似文献
1
Challenges in interpreting SARS-CoV-2 serological results in African countries.非洲国家在解读新冠病毒血清学检测结果方面面临的挑战。
Lancet Glob Health. 2021 May;9(5):e588-e589. doi: 10.1016/S2214-109X(21)00060-7. Epub 2021 Feb 17.
2
Interpreting a lateral flow SARS-CoV-2 antigen test.解读新冠病毒2型侧向流动抗原检测结果。
BMJ. 2021 Jun 22;373:n1411. doi: 10.1136/bmj.n1411.
3
Performance of a Rapid SARS-CoV-2 Antigen Detection Assay in Symptomatic Children.快速严重急性呼吸综合征冠状病毒2（SARS-CoV-2）抗原检测法在有症状儿童中的性能评估
Pediatrics. 2021 Sep;148(3). doi: 10.1542/peds.2021-050832. Epub 2021 May 26.
4
Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients.通过快速诊断免疫分析检测 COVID-19 患者的 SARS-CoV-2 特异性抗体。
Virol J. 2021 Mar 9;18(1):52. doi: 10.1186/s12985-021-01530-2.
5
Serological antibody testing in the COVID-19 pandemic: their molecular basis and applications.新型冠状病毒肺炎大流行中的血清学抗体检测：其分子基础与应用。
Biochem Soc Trans. 2020 Dec 18;48(6):2851-2863. doi: 10.1042/BST20200744.
6
Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19.新型冠状病毒血清学检测方法在 SARS-CoV-2 感染和 COVID-19 诊断中的研究进展。
Front Public Health. 2021 Feb 18;8:620222. doi: 10.3389/fpubh.2020.620222. eCollection 2020.
7
Associating SARS-CoV-2 Serological Assays with Protection: Where the Field Stands.将严重急性呼吸综合征冠状病毒2血清学检测与保护作用相关联：该领域现状
Clin Chem. 2021 Apr 29;67(5):707-709. doi: 10.1093/clinchem/hvab039.
8
An original multiplex method to assess five different SARS-CoV-2 antibodies.一种评估五种不同 SARS-CoV-2 抗体的原始多重方法。
Clin Chem Lab Med. 2020 Dec 21;59(5):971-978. doi: 10.1515/cclm-2020-1652. Print 2021 Apr 27.
9
Self-testing for SARS-CoV-2: importance of lay communication.新型冠状病毒2019（SARS-CoV-2）的自我检测：大众沟通的重要性
Swiss Med Wkly. 2021 Jun 5;151:w20526. doi: 10.4414/smw.2021.20526. eCollection 2021 May 24.
10
Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points to IgM as the Achilles heel.用 SARS-CoV-2 IgG-IgM 抗体快速检测试剂盒检测来自欧洲和非洲的大流行前血标本时，出现了出乎意料的高频率非特异性反应，这表明 IgM 是“阿喀琉斯之踵”。
J Med Virol. 2021 Apr;93(4):2196-2203. doi: 10.1002/jmv.26628. Epub 2020 Nov 22.
引用本文的文献
1
COVID-19 seroprevalence cohort survey among health care workers and their household members in Kinshasa, DR Congo, 2020-2022.2020-2022 年，刚果民主共和国金沙萨卫生工作者及其家庭成员中的 COVID-19 血清流行率队列调查。
J Health Popul Nutr. 2024 Jun 1;43(1):74. doi: 10.1186/s41043-024-00536-0.
2
Tracking SARS-CoV-2 seropositivity in rural communities using blood-fed mosquitoes: a proof-of-concept study.利用吸食血液的蚊子追踪农村社区中新冠病毒的血清阳性率：一项概念验证研究。
Front Epidemiol. 2023 Dec 13;3:1243691. doi: 10.3389/fepid.2023.1243691. eCollection 2023.
3
The burden of the coronavirus disease 2019 virus infection in Burkina Faso: Results from a World Health Organization UNITY population-based, age-stratified sero-epidemiological investigation.布基纳法索 2019 冠状病毒病病毒感染负担：世界卫生组织 UNITY 基于人群、年龄分层血清流行病学调查结果。
Influenza Other Respir Viruses. 2023 Nov;17(11):e13216. doi: 10.1111/irv.13216.
4
Alternative epidemic indicators for COVID-19 in three settings with incomplete death registration systems.在三个死亡登记系统不完善的地区，用于 COVID-19 的替代流行指标。
Sci Adv. 2023 Jun 9;9(23):eadg7676. doi: 10.1126/sciadv.adg7676.
5
Seroprevalence of SARS-CoV-2 antibodies and retrospective mortality in two African settings: Lubumbashi, Democratic Republic of the Congo and Abidjan, Côte d'Ivoire.刚果民主共和国卢本巴希和科特迪瓦阿比让这两个非洲地区的新冠病毒抗体血清流行率及回顾性死亡率
PLOS Glob Public Health. 2023 Jun 8;3(6):e0001457. doi: 10.1371/journal.pgph.0001457. eCollection 2023.
6
Large Diffusion of Severe Acute Respiratory Syndrome Coronavirus 2 After the Successive Epidemiological Waves, Including Omicron, in Guinea and Cameroon: Implications for Vaccine Strategies.在几内亚和喀麦隆经历包括奥密克戎在内的连续疫情浪潮后，严重急性呼吸综合征冠状病毒2的广泛传播：对疫苗策略的影响
Open Forum Infect Dis. 2023 Apr 20;10(5):ofad216. doi: 10.1093/ofid/ofad216. eCollection 2023 May.
7
Seroprevalence of SARS-CoV-2 in four states of Nigeria in October 2020: A population-based household survey.2020年10月尼日利亚四个州的新冠病毒血清阳性率：一项基于人群的家庭调查。
PLOS Glob Public Health. 2022 Jun 17;2(6):e0000363. doi: 10.1371/journal.pgph.0000363. eCollection 2022.
8
Field evaluation of specificity and sensitivity of a standard SARS-CoV-2 antigen rapid diagnostic test: A prospective study at a teaching hospital in Northern Ghana.标准SARS-CoV-2抗原快速诊断检测特异性和敏感性的现场评估：加纳北部一家教学医院的前瞻性研究。
PLOS Glob Public Health. 2021 Dec 7;1(12):e0000040. doi: 10.1371/journal.pgph.0000040. eCollection 2021.
9
Comparison of one single-antigen assay and three multi-antigen SARS-CoV-2 IgG assays in Nigeria.尼日利亚一种单抗原检测法与三种多抗原新冠病毒 IgG 检测法的比较。
J Clin Virol Plus. 2023 Feb;3(1):100139. doi: 10.1016/j.jcvp.2023.100139. Epub 2023 Jan 13.
10
Dynamics of SARS-CoV-2 exposure in Malawian infants between February 2020 and May 2021.2020年2月至2021年5月期间马拉维婴儿中新冠病毒暴露情况的动态变化
J Clin Virol Plus. 2022 Nov;2(4):100110. doi: 10.1016/j.jcvp.2022.100110. Epub 2022 Sep 16.
本文引用的文献
1
Limited Specificity of Serologic Tests for SARS-CoV-2 Antibody Detection, Benin.血清学检测用于 SARS-CoV-2 抗体检测的特异性有限，贝宁。
Emerg Infect Dis. 2021 Jan;27(1):233-7. doi: 10.3201/eid2701.203281. Epub 2020 Dec 1.
2
SARS-CoV-2 Seropositivity in Asymptomatic Frontline Health Workers in Ibadan, Nigeria.尼日利亚伊巴丹市无症状一线卫生工作者中 SARS-CoV-2 血清阳性率。
Am J Trop Med Hyg. 2021 Jan;104(1):91-94. doi: 10.4269/ajtmh.20-1235.
3
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors.肯尼亚献血者中抗 SARS-CoV-2 IgG 抗体的血清流行率。
Science. 2021 Jan 1;371(6524):79-82. doi: 10.1126/science.abe1916. Epub 2020 Nov 11.
4
High prevalence of pre-existing serological cross-reactivity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in sub-Saharan Africa.撒哈拉以南非洲地区存在严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）血清学交叉反应的高流行率。
Int J Infect Dis. 2021 Jan;102:577-583. doi: 10.1016/j.ijid.2020.10.104. Epub 2020 Nov 8.
5
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans.人类对 SARS-CoV-2 的预先存在和新产生的体液免疫。
Science. 2020 Dec 11;370(6522):1339-1343. doi: 10.1126/science.abe1107. Epub 2020 Nov 6.
6
SARS-CoV-2 Serosurvey in Addis Ababa, Ethiopia.埃塞俄比亚亚的斯亚贝巴的 SARS-CoV-2 血清学调查。
Am J Trop Med Hyg. 2020 Nov;103(5):2022-2023. doi: 10.4269/ajtmh.20-0816.
7
Serology testing in the COVID-19 pandemic response.新冠疫情应对中的血清学检测。
Lancet Infect Dis. 2020 Sep;20(9):e245-e249. doi: 10.1016/S1473-3099(20)30517-X. Epub 2020 Jul 17.
8
Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies.评价两种自动化和三种快速侧向流动免疫测定法用于检测抗 SARS-CoV-2 抗体。
J Clin Virol. 2020 Jul;128:104413. doi: 10.1016/j.jcv.2020.104413. Epub 2020 May 5.
9
Interrater reliability: the kappa statistic.组内一致性：kappa 统计量。
Biochem Med (Zagreb). 2012;22(3):276-82.
10
Comparative evaluation of 36 commercial assays for detecting antibodies to HIV.36种用于检测HIV抗体的商业检测方法的比较评估。
Bull World Health Organ. 1991;69(6):753-60.
Zotero 插件